Download PDF
Semin Liver Dis 2016; 36(02): 133-140
DOI: 10.1055/s-0036-1583199
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

The Pathogenesis of ACLF: The Inflammatory Response and Immune Function

Richard Moreau
1   Inserm, U1149, Centre de Recherche sur l'Inflammation (CRI), Clichy and Paris, France
2   UMRS1149, Université Paris Diderot-Paris 7, Paris, France
3   Département Hospitalo-Universitaire (DHU) UNITY, Service d'Hépatologie, Hôpital Beaujon, Assistance Publique-Hôpitaux de Paris, Clichy, France
4   Laboratoire d'Excellence Inflamex, ComUE Sorbonne Paris Cité, Paris, France
› Author Affiliations
Further Information

Publication History

Publication Date:
12 May 2016 (online)

    Permissions and Reprints

Abstract

Although systemic inflammation is a hallmark of acute-on-chronic liver failure (ACLF), its role in the development of this syndrome is poorly understood. Here the author first summarizes the general principles of the inflammatory response. Inflammation can be triggered by exogenous or endogenous inducers. Important exogenous inducers include bacterial products such as pathogen-associated molecular patterns (PAMPs) and virulence factors. Pathogen-associated molecular patterns elicit inflammation through structural feature recognition (using innate pattern-recognition receptors [PRRs]), whereas virulence factors generally trigger inflammation via functional feature recognition. Endogenous inducers are called danger-associated molecular patterns (DAMPs) and include molecules released by necrotic cells and products of extracellular matrix breakdown. Danger-associated molecular patterns use different PRRs. The purpose of the inflammatory response may differ according to the type of stimulus: The aim of infection-induced inflammation is to decrease pathogen burden, whereas the DAMP-induced inflammation aims to promote tissue repair. An excessive inflammatory response can induce collateral tissue damage (a process called immunopathology). However immunopathology may not be the only mechanism of tissue damage; for example, organ failure can develop because of failed disease tolerance. In this review, the author also discusses how general principles of the inflammatory response can help us to understand the development of ACLF in different contexts: bacterial infection, severe alcoholic hepatitis, and cases in which there is no identifiable trigger.

Keywords

inflammation - pattern recognition receptors - immunopathology - tolerance - cirrhosis
 

  • References

  • 1 Moreau R, Jalan R, Gines P , et al; CANONIC Study Investigators of the EASL–CLIF Consortium. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology 2013; 144 (7) 1426-1437 , 1437.e1–1437.e9
    CrossrefPubMedGoogle Scholar
  • 2 Medzhitov R. Origin and physiological roles of inflammation. Nature 2008; 454 (7203) 428-435
    CrossrefPubMedGoogle Scholar
  • 3 Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010; 140 (6) 805-820
    CrossrefPubMedGoogle Scholar
  • 4 Iwasaki A, Medzhitov R. Control of adaptive immunity by the innate immune system. Nat Immunol 2015; 16 (4) 343-353
    CrossrefPubMedGoogle Scholar
  • 5 Zhao Y, Yang J, Shi J , et al. The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. Nature 2011; 477 (7366) 596-600
    CrossrefPubMedGoogle Scholar
  • 6 Kayagaki N, Wong MT, Stowe IB , et al. Noncanonical inflammasome activation by intracellular LPS independent of TLR4. Science 2013; 341 (6151) 1246-1249
    CrossrefPubMedGoogle Scholar
  • 7 Shi J, Zhao Y, Wang Y , et al. Inflammatory caspases are innate immune receptors for intracellular LPS. Nature 2014; 514 (7521) 187-192
    PubMedGoogle Scholar
  • 8 Martinon F, Mayor A, Tschopp J. The inflammasomes: guardians of the body. Annu Rev Immunol 2009; 27: 229-265
    CrossrefPubMedGoogle Scholar
  • 9 Xu H, Yang J, Gao W , et al. Innate immune sensing of bacterial modifications of Rho GTPases by the pyrin inflammasome. Nature 2014; 513 (7517) 237-241
    CrossrefPubMedGoogle Scholar
  • 10 Moura-Alves P, Faé K, Houthuys E , et al. AhR sensing of bacterial pigments regulates antibacterial defence. Nature 2014; 512 (7515) 387-392
    CrossrefPubMedGoogle Scholar
  • 11 Kono H, Rock KL. How dying cells alert the immune system to danger. Nat Rev Immunol 2008; 8 (4) 279-289
    Google Scholar
  • 12 Rickard JA, O'Donnell JA, Evans JM , et al. RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis. Cell 2014; 157 (5) 1175-1188
    CrossrefPubMedGoogle Scholar
  • 13 Zhang Q, Raoof M, Chen Y , et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010; 464 (7285) 104-107
    CrossrefPubMedGoogle Scholar
  • 14 Medzhitov R, Schneider DS, Soares MP. Disease tolerance as a defense strategy. Science 2012; 335 (6071) 936-941
    CrossrefPubMedGoogle Scholar
  • 15 Jamieson AM, Pasman L, Yu S , et al. Role of tissue protection in lethal respiratory viral-bacterial coinfection. Science 2013; 340 (6137) 1230-1234
    CrossrefPubMedGoogle Scholar
  • 16 Zaiss DM, Gause WC, Osborne LC, Artis D. Emerging functions of amphiregulin in orchestrating immunity, inflammation, and tissue repair. Immunity 2015; 42 (2) 216-226
    CrossrefPubMedGoogle Scholar
  • 17 Figueiredo N, Chora A, Raquel H , et al. Anthracyclines induce DNA damage response-mediated protection against severe sepsis. Immunity 2013; 39 (5) 874-884
    CrossrefPubMedGoogle Scholar
  • 18 Jalan R, Fernandez J, Wiest R , et al. Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. J Hepatol 2014; 60 (6) 1310-1324
    CrossrefPubMedGoogle Scholar
  • 19 Wiest R, Lawson M, Geuking M. Pathological bacterial translocation in liver cirrhosis. J Hepatol 2014; 60 (1) 197-209
    CrossrefPubMedGoogle Scholar
  • 20 Bernardi M, Moreau R, Angeli P, Schnabl B, Arroyo V. Mechanisms of decompensation and organ failure in cirrhosis: from peripheral arterial vasodilation to systemic inflammation hypothesis. J Hepatol 2015; 63 (5) 1272-1284
    CrossrefPubMedGoogle Scholar
  • 21 Navasa M, Follo A, Filella X , et al. Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality. Hepatology 1998; 27 (5) 1227-1232
    CrossrefPubMedGoogle Scholar
  • 22 Hugot JP, Chamaillard M, Zouali H , et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411 (6837) 599-603
    CrossrefPubMedGoogle Scholar
  • 23 Appenrodt B, Grünhage F, Gentemann MG, Thyssen L, Sauerbruch T, Lammert F. Nucleotide-binding oligomerization domain containing 2 (NOD2) variants are genetic risk factors for death and spontaneous bacterial peritonitis in liver cirrhosis. Hepatology 2010; 51 (4) 1327-1333
    CrossrefPubMedGoogle Scholar
  • 24 Nish S, Medzhitov R. Host defense pathways: role of redundancy and compensation in infectious disease phenotypes. Immunity 2011; 34 (5) 629-636
    CrossrefPubMedGoogle Scholar
  • 25 Orozco LD, Bennett BJ, Farber CR , et al. Unraveling inflammatory responses using systems genetics and gene-environment interactions in macrophages. Cell 2012; 151 (3) 658-670
    CrossrefPubMedGoogle Scholar
  • 26 Lucey MR, Mathurin P, Morgan TR. Alcoholic hepatitis. N Engl J Med 2009; 360 (26) 2758-2769
    CrossrefPubMedGoogle Scholar
  • 27 Dominguez M, Miquel R, Colmenero J , et al. Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis. Gastroenterology 2009; 136 (5) 1639-1650
    CrossrefPubMedGoogle Scholar
  • 28 Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 2006; 354 (6) 610-621
    CrossrefPubMedGoogle Scholar
  • 29 Altamirano J, Miquel R, Katoonizadeh A , et al. A histologic scoring system for prognosis of patients with alcoholic hepatitis. Gastroenterology 2014; 146 (5) 1231-9.e1 , 6
    CrossrefPubMedGoogle Scholar
  • 30 Zhang K, Shen X, Wu J , et al. Endoplasmic reticulum stress activates cleavage of CREBH to induce a systemic inflammatory response. Cell 2006; 124 (3) 587-599
    CrossrefPubMedGoogle Scholar
  • 31 Tazi KA, Bièche I, Paradis V , et al. In vivo altered unfolded protein response and apoptosis in livers from lipopolysaccharide-challenged cirrhotic rats. J Hepatol 2007; 46 (6) 1075-1088
    CrossrefPubMedGoogle Scholar
  • 32 Chovatiya R, Medzhitov R. Stress, inflammation, and defense of homeostasis. Mol Cell 2014; 54 (2) 281-288
    CrossrefPubMedGoogle Scholar
  • 33 Singh V, Sharma AK, Narasimhan RL, Bhalla A, Sharma N, Sharma R. Granulocyte colony-stimulating factor in severe alcoholic hepatitis: a randomized pilot study. Am J Gastroenterol 2014; 109 (9) 1417-1423
    CrossrefPubMedGoogle Scholar
  • 34 Dubuquoy L, Louvet A, Lassailly G , et al. Progenitor cell expansion and impaired hepatocyte regeneration in explanted livers from alcoholic hepatitis. Gut 2015; 64 (12) 1949-1960
    CrossrefPubMedGoogle Scholar
  • 35 Michelena J, Altamirano J, Abraldes JG , et al. Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis. Hepatology 2015; 62 (3) 762-772
    CrossrefPubMedGoogle Scholar
  • 36 Qin N, Yang F, Li A , et al. Alterations of the human gut microbiome in liver cirrhosis. Nature 2014; 513 (7516) 59-64
    CrossrefPubMedGoogle Scholar
  • 37 Bajaj JS, Heuman DM, Hylemon PB , et al. Altered profile of human gut microbiome is associated with cirrhosis and its complications. J Hepatol 2014; 60 (5) 940-947
    CrossrefPubMedGoogle Scholar
  • 38 Bajaj JS, Ridlon JM, Hylemon PB , et al. Linkage of gut microbiome with cognition in hepatic encephalopathy. Am J Physiol Gastrointest Liver Physiol 2012; 302 (1) G168-G175
    CrossrefPubMedGoogle Scholar
  • 39 Chen Y, Yang F, Lu H , et al. Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology 2011; 54 (2) 562-572
    CrossrefPubMedGoogle Scholar
  • 40 Chen Y, Guo J, Qian G , et al. Gut dysbiosis in acute-on-chronic liver failure and its predictive value for mortality. J Gastroenterol Hepatol 2015; 30 (9) 1429-1437
    CrossrefPubMedGoogle Scholar
  • 41 Bauer TM, Schwacha H, Steinbrückner B , et al. Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia. Am J Gastroenterol 2002; 97 (9) 2364-2370
    CrossrefPubMedGoogle Scholar
  • 42 Zapater P, Francés R, González-Navajas JM , et al. Serum and ascitic fluid bacterial DNA: a new independent prognostic factor in noninfected patients with cirrhosis. Hepatology 2008; 48 (6) 1924-1931
    CrossrefPubMedGoogle Scholar
  • 43 Bernsmeier C, Pop OT, Singanayagam A , et al. Patients with acute-on-chronic liver failure have increased numbers of regulatory immune cells expressing the receptor tyrosine kinase MERTK. Gastroenterology 2015; 148 (3) 603-615.e14
    CrossrefPubMedGoogle Scholar
  • 44 Zagórska A, Través PG, Lew ED, Dransfield I, Lemke G. Diversification of TAM receptor tyrosine kinase function. Nat Immunol 2014; 15 (10) 920-928
    CrossrefPubMedGoogle Scholar
  • 45 O'Brien AJ, Fullerton JN, Massey KA , et al. Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2. Nat Med 2014; 20 (5) 518-523
    CrossrefPubMedGoogle Scholar
  • 46 Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol 2013; 13 (12) 862-874
    CrossrefPubMedGoogle Scholar
  • 47 Wasmuth HE, Kunz D, Yagmur E , et al. Patients with acute on chronic liver failure display “sepsis-like” immune paralysis. J Hepatol 2005; 42 (2) 195-201
    PubMedGoogle Scholar